CPA |
C |
43 |
3 μg |
Necrotizing, hemolytic, contraction of smooth muscle |
Susceptible |
Phospholipase C; activates host cell signaling |
CPB |
P |
35 |
<400 ng |
Dermonecrosis, edema, enterotoxic |
Susceptible |
Pore former |
ETX |
P |
34 |
100 ng |
Dermonecrosis, edema, contraction of smooth muscle |
Activation required |
Pore former |
ITX |
P |
Ia, 48; Ib, 72 |
40 μg |
Necrotizing |
Activation required |
ADP-ribosylating action |
PFO |
C |
54 |
15 μg |
Necrotizing |
Susceptible |
Pore former |
CPE |
C/P |
35 |
81 μg |
Erythema, enterotoxic |
Activation but not required |
Pore former |
CPB2 |
P |
28 |
160 μg |
Dermonecrosis, edema, enterotoxic |
Susceptible |
? |
TpeL |
P |
191 |
600 μg |
? |
? |
Glycosylates Ras |
NetB |
P |
33 |
? |
Hemolytic |
? |
Pore former |